No Mere Trivia
Mar 13, 2017
Jeremy Parkinson
Finance
We are at the stage ten years later where it is still necessary to define terms. In every finance and economics textbook, the chapter on monetary policy defines “tight” money as when the Federal Reserve (or whatever central bank) raises its policy rate(s). Conversely, “accommodative” money is where it lowers the rate(s). In the US […]
Solutions Abound – On The Local Level
Mar 13, 2017
Jeremy Parkinson
Finance
Those looking for centralized solutions to healthcare, jobs and other “macro-problems” will suffer inevitable disappointment. The era in which further centralization provided the “solution” has passed: additional centralization (Medicare for All, No Child Left Behind, federal job training, Universal Basic Income, central banking “free money for financiers”, etc.) have all entered Diminishing Returns. The systemic costs […]
SEC Denies Bitcoin ETF: Bitcoin’s Price Crashes
Mar 13, 2017
Jeremy Parkinson
Finance
In this article, I will discuss the latest developments in European monetary policy and review an interesting chart which shows historical real labor unit costs, but first I will react to the breaking news about bitcoin which was released Friday afternoon. Bitcoin ETF Denied The, much heralded by the media, Winklevoss Bitcoin ETF was denied […]
77 Bullish Stocks To Consider
Mar 13, 2017
Jeremy Parkinson
Finance
Plenty of bullish stocks to be following The number of bearish stocks are ticking upwards as well, but for right now, I only want to focus on the bullish stocks. Bearish stocks will be posted soon enough. Nonetheless, stocks like Apple (AAPL) which has been on a huge tear of late, is setting up, yet again, to […]
Energy Stocks Could Collapse If This Happens
Mar 13, 2017
Jeremy Parkinson
Finance
Last year, we saw in this crude oil price forecast that crude would face an incredibly strong resistance area between $54 and $60. InvestingHaven’s analysts wrote that energy stocks would be very bullish only if crude’s resistance area would be broken to the upside. However, so far that scenario hasn’t materialized, and energy stocks are facing a serious breakdown threat at this […]
GameStop: A 6% Yield, But Is The Dividend Safe?
Mar 13, 2017
Jeremy Parkinson
Finance
At a glance, GameStop (GME) is a tempting dividend stock for retired income investors. GameStop offers a high dividend yield in excess of 6% and has increased its dividend every year since initiating its dividend program in 2012. The company has a healthy payout ratio near 40% and consistently generates positive free cash flow as well. […]
Ackman Sells Entire Stake In Valeant Pharmaceuticals Intl, Inc. – Stock Plunges
Mar 13, 2017
Jeremy Parkinson
Finance
Written by BNN.ca Billionaire investor William Ackman walked away from Valeant Pharmaceuticals Intl Inc. (NYSE: VRX) on Monday, with a roughly $3 billion loss after he sold his entire stake in the ailing drug company despite trying to rescue it for some 18 months. Ackman’s Pershing Square Capital Management disclosed the exit in a press release […]
Will Mid-March Madness Maul The Stock Market In 2017?
Mar 13, 2017
Jeremy Parkinson
Finance
Many of the 2017 economic headwinds I’ve described will hit during the Ides of March, just as the Trump Rally shows signs of topping out. Likely a correction is looming. I think the bear is about to be let out of his cage. Chaos emerged in emerging-market stocks last week, bond prices plummeted (yields rose to match their last 2016 high), stock-market volatility rose, and […]
Tentative Gains
Mar 13, 2017
Jeremy Parkinson
Finance
Not a whole lot to say about today. The Semiconductor Index gained nearly 1% as it pushed a new multi-year high, but most of the gains were achieved by the open and it didn’t add too much after that. However, it did keep shorts at bay for another day (resistance remains former channel support). Aside […]
Corcept Therapeutics – Chart Of The Day
Mar 13, 2017
Jeremy Parkinson
Finance
Summary 14 new highs and up 27.78% in the last month 100% technical buy signals Earnings estimated to increase 53.80% next year Corcept Therapeutics (CORT) Incorporated is a pharmaceutical company. It is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The company focuses on […]